Artelo Biosciences, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

LEASE (Tables)

LEASE (Tables)

9 Months Ended

Sep. 30, 2025

Schedule of operating lease right-of use assets and lease information

		Nine Months Ended
		September 30,
		2025				2024

Lease cost
Operating lease cost		$	26			$	24

Other information
Cash paid for operating cash flows from operating leases		$	26			$	22
Right-of-use assets obtained in exchange for new operating lease liability		$	-			$	111

Weighted-average remaining lease term — operating leases (year)			1.83				2.83
Weighted-average discount rate — operating leases			7.50	%			7.50	%

Schedule of operating lease liabilities future minimum lease payments

		Total
Year Ended December 31,
2025		$	11
2026			43
2027			30
2028			-
Thereafter			-
			84
Less: Imputed interest			(5	)
Operating lease liabilities			79

Operating lease liability - current			39
Operating lease liability - non-current		$	40